Francesco Menzella Selected Research

Francesco Menzella Research Topics

Disease

61	Asthma (Bronchial Asthma) 04/2024 - 05/2011
4	Bronchiectasis 01/2023 - 05/2019
4	Inflammation (Inflammations) 04/2022 - 01/2016
4	COVID-19 07/2021 - 01/2020
4	Pneumonia (Pneumonitis) 04/2021 - 11/2010
3	Eosinophilia 01/2024 - 01/2015
3	Rhinosinusitis 01/2024 - 01/2021
3	Fever (Fevers) 01/2022 - 01/2019
2	Allergic Rhinitis 06/2023 - 05/2019
2	Food Hypersensitivity (Food Allergy) 06/2023 - 05/2019
2	Respiratory Tract Infections (Respiratory Tract Infection) 11/2022 - 10/2020
2	Nasal Polyps (Nasal Polyp) 01/2022 - 01/2021
2	Headache (Headaches) 01/2022 - 01/2021
2	Sinusitis 01/2022 - 01/2021
2	Respiratory Insufficiency (Respiratory Failure) 07/2021 - 01/2018
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2021 - 11/2010
2	Virus Diseases (Viral Diseases) 03/2021 - 01/2020
2	Infections 10/2020 - 01/2020
1	Disease Progression 01/2024
1	Allergic Bronchopulmonary Aspergillosis 06/2023
1	Atopic Dermatitis (Atopic Eczema) 06/2023
1	Body Weight (Weight, Body) 06/2023
1	Reinfection 11/2022
1	Cystic Fibrosis (Mucoviscidosis) 08/2022
1	Human Influenza (Influenza) 01/2022
1	Pneumococcal Infections 04/2021
1	Vasculitis (Vasculitides) 01/2021
1	Systemic Vasculitis 01/2021
1	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021
1	Nasopharyngitis 01/2021
1	Neoplasms (Cancer) 01/2021
1	Chronic Urticaria 01/2021
1	Bronchitis 01/2021
1	Malignant Mesothelioma 01/2021
1	Cytokine Release Syndrome 01/2020
1	Gastroesophageal Reflux (GERD) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Lung Injury 01/2020
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2019
1	Necrosis 01/2018

Drug/Important Bio-Agent (IBA)

24	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 01/2015
20	benralizumabIBA 01/2024 - 01/2015
16	Omalizumab (Xolair)FDA Link 01/2024 - 05/2011
15	mepolizumabIBA 01/2024 - 01/2015
9	Immunoglobulin E (IgE)IBA 06/2023 - 05/2011
8	Monoclonal AntibodiesIBA 04/2024 - 01/2015
6	Interleukin-5 (Interleukin 5)IBA 10/2020 - 01/2015
5	CytokinesIBA 04/2024 - 01/2015
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
3	Oxygen (Dioxygen)IBA 01/2020 - 12/2012
3	SteroidsIBA 10/2019 - 05/2011
3	reslizumabIBA 01/2019 - 01/2015
2	tezepelumabIBA 04/2024 - 02/2023
2	dupilumabIBA 01/2024 - 01/2019
2	anti-IgE antibodiesIBA 06/2023 - 03/2021
2	Bronchodilator Agents (Bronchodilators)IBA 05/2023 - 01/2015
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 08/2022 - 01/2021
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2021 - 01/2021
2	tocilizumab (atlizumab)FDA Link 11/2020 - 01/2020
2	Interleukin-13IBA 10/2020 - 01/2015
1	AlarminsIBA 04/2024
1	Prednisone (Sone)FDA LinkGeneric 01/2024
1	AllergensIBA 06/2023
1	Immunomodulating AgentsIBA 11/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2022
1	cysteinyl-leukotrieneIBA 08/2022
1	leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA 08/2022
1	LeukotrienesIBA 08/2022
1	Messenger RNA (mRNA)IBA 05/2022
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 05/2022
1	Conjugate VaccinesIBA 04/2021
1	Antiviral Agents (Antivirals)IBA 03/2021
1	Muscarinic AntagonistsIBA 01/2021
1	Theophylline (Theon)FDA LinkGeneric 01/2021
1	AsbestosIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 11/2020
1	Interleukin-4 (Interleukin 4)IBA 10/2020
1	Bacterial LysatesIBA 10/2020
1	ChemokinesIBA 10/2020
1	Chemokine CCL24IBA 10/2020
1	Interleukin-33IBA 10/2020
1	Thymic Stromal LymphopoietinIBA 10/2020
1	beta-Lactamases (beta-Lactamase)IBA 01/2020
1	mesoglycanIBA 01/2019
1	InterleukinsIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2018
1	alpha-Glucosidases (Acid Maltase)IBA 01/2018

Therapy/Procedure

20	Therapeutics 04/2024 - 05/2011
9	Bronchial Thermoplasty 05/2022 - 07/2014
8	Biological Therapy 01/2024 - 01/2017
3	Noninvasive Ventilation 07/2021 - 01/2015
3	Artificial Respiration (Mechanical Ventilation) 01/2020 - 01/2018
3	Precision Medicine 01/2020 - 01/2018
1	Hospital to Home Transition 01/2022
1	Continuous Positive Airway Pressure 07/2021
1	Nebulizers and Vaporizers (Inhaler) 01/2021
1	Self Administration (Administration, Self) 01/2021
1	Immunomodulation 10/2020